REVIEW ARTICLE
Environment and urinary bladder cancer. A historical perspective
More details
Hide details
1
University of Florence, Florence, Italy
2
University of Magna Graecia, Catanzaro, Italy
3
Careggi University Hospital, Florence, Italy
Submission date: 2019-01-31
Acceptance date: 2019-02-01
Publication date: 2019-04-24
Pol J Pathol 2019;70(1):21-25
KEYWORDS
TOPICS
ABSTRACT
Our understanding of aetiological factors associated with urinary bladder cancer has radically improved over the last decades. Cigarette smoking is considered the most important risk factor, even in the industrialised world, while various occupational and environmental exposures to chemicals are also held responsible. The link between bladder cancer and schistosomiasis, highly prevalent in sub-Saharan Africa, Sudan, Egypt, and Yemen, provides input for investigating and potentially preventing bladder carcinogenesis. Growing concern regarding environmental diseases prompts investigation into the historical milestones that have helped disentangle the relationships between health and environment.
REFERENCES (34)
1.
Letasiova S, Medveova A, Sovcíkova A, et al. Bladder cancer, a review of the environmental risk factors. Environ Health 2012; 11 Suppl 1: S11.
2.
World Health Organization classification of tumours of the urinary system and male genital organs. Moch H, Humphrey PA, Ulbright TM, Reuter VE (eds.). IARC Press, Lyon 2016.
3.
Bryan GT. Pathogenesis of human urinary bladder cancer. Environ Health Perspect 1983; 49: 201-207.
4.
Chung KT. Occurrence, uses, and carcinogenicity of arylamines. Front Biosci (Elite Ed) 2015; 7: 322-345.
5.
Domico T. Wild Harvest Edible Plants of the Pacific Northwest. Hancock Home Publishers Inc. Seattle 1979; 86.
6.
Potter DM, Baird MS. Carcinogenic effects of ptaquiloside in bracken fern and related compounds. Br J Cancer 2000; 83: 914-920.
7.
Hughes MF, Beck BD, Chen Y, et al. Arsenic exposure and toxicology: a historical perspective. Toxicol Sci 2011; 123: 305-332.
8.
Paris JA. Pharmacologia; comprehending the art of prescribing upon fixed and scientific principles together with the history of medicinal substances. 5th ed. W. Phillips, London 1822.
9.
White JC. Psoriasis-verruca-epithelioma: a sequence. Am J Med Sci 1885; 89: 163-173.
10.
Gontijo B, Bittencourt F. Arsenic. A historical review. An Bras Dermatol 2005; 80: 81-85.
11.
Bouvard V, Baan R, Straif K, et al. A review of human carcinogens – Part B: biological agents. Lancet Oncol 2009; 10: 321-322.
12.
Khaled H. Schistosomiasis and cancer in Egypt: review. J Adv Res 2013; 4: 461-466.
13.
Bilharz T. Further observations concerning Distomum haematobium in the portal vein of man and its relationship to certain pathological formations with brief notes by Seibald. Z Wiss Zool 1853; 4: 72.
14.
Leiper RT, Atkinson EL. Observations on the spread of Asiatic schistosomiasis. Br Med J 1915; 1: 192-194, 201-203.
15.
Berry A, Iriart X, Fillaux J, Magnaval JF. Urinary schistosomiasis and cancer. Bull Soc Pathol Exot 2017; 110: 68-75.
16.
Nash TE, Cheever AW, Ottesen EA, Cook JA. Schistosome infections in humans: perspectives and recent findings. NIH conference. Ann Intern Med 1982; 97: 740-754.
17.
World Health Organization. Evaluation of carcinogenic risk to humans.Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr 1994; 61: 45-119.
18.
Barakat RM. Epidemiology of Schistosomiasis in Egypt: Travel through Time: Review. J Adv Res 2013; 4: 425-432.
19.
Ruffer M. Note on the presence of ‘‘Bilharzia haematobia’’ in Egyptian mummies of the twentieth dynasty. Br Med J 1910; 1: 16.
20.
David A. Disease in Egyptian mummies: the contribution of new technologies. Lancet 1997; 349: 1760-1763.
21.
Deelder A, Miller N, De Longe M, Krijker F. Detection of schistosome antigen in mummies. Lancet 1990; 335: 724-725.
22.
Contis G, David A. The epidemiology of Bilharzia in ancient Egypt: 5000 years of schistosomiasis. Parasitol Today 1996; 12: 253-255.
23.
Ayer WD. Napoleon Buonaparte and schistosomiasis or bilharziasis. NY State J Med 1966; 66: 2295-2301.
24.
Mostafa MH, Sheweita SA, O’Connor PJ. Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev 1999; 12: 97-111.
25.
Rosin MP, Anwar WA, Ward AJ. Inflammation, chromosomal instability, and cancer: the schistosomiasis model. Cancer Res 1994; 54 (7 Suppl): 1929s-1933s.
26.
Nesi G, Nobili S, Cai T, et al. Chronic inflammation in urothelial bladder cancer. Virchows Arch 2015; 467: 623-633.
27.
Lower GM Jr. Concepts in causality: chemically induced human urinary bladder cancer. Cancer 1982; 49: 1056-1066.
28.
Freedman ND, Silverman DT, Hollenbeck AR, et al. Association between smoking and risk of bladder cancer among men and women. JAMA 2011; 306: 737-745.
29.
Ramazzini B. De Morbis Artificum Diatriba [Diseases of Workers]. Carnevale F (curator). Carocci Editore, Rome 1982.
30.
Dietrich HG, Golka K. Bladder tumors and aromatic amines – historical milestones from Ludwig Rehn to Wilhelm Hueper. Front Biosci (Elite Ed) 2012; 4: 279-288.
31.
Case RA, Hosker ME, McDonald DB, et al. Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. I. The role of aniline, benzidine, alpha-naphthylamine, and beta-naphthylamine. Br J Ind Med 1954; 11: 75-104.
32.
Melick WF, Escue HM, Naryka JJ, et al. The first reported cases of human bladder tumors due to a new carcinogen-xenylamine. J Urol 1955; 74: 760-766.
33.
Golka K, Wiese A, Assennato G, Bolt HM. Occupational exposure and urological cancer. World J Urol 2004; 21: 382-391.
34.
Hueper WC, Wiley FH, Wolfe HD. Experimental production of bladdertumors in dogs by administration of ß-naphthylamine. J Ind Hyg Tox 1938; 20: 46-84.